DRG Epidemiology's coverage of OSA comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the prevalence of OSA for each country as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets.
DRG Epidemiology's OSA forecast will answer the following questions:
How will changes in the levels of exposure to known risk or protective factors affect the number of people living with OSA?
How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of OSA over the forecast period?
All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
In addition to the total number of cases for each forecast year, DRG Epidemiology provides at least ten years of forecast data for the following OSA subpopulations:
Total Prevalence of Obstructive Sleep Apnea per 1,000 People Aged 20+ in 2021 and 2041ttttttttt
Relative Sizes of the Factors Contributing to the Trend in Total Prevalent Cases of Obstructive Sleep Apnea Over the Next 20 Yearsttttttttt
Number of Additional Total Prevalent Cases of Obstructive Sleep Apnea in 2041 in the Countries Under Study due to Trends in Risk or Survivalttttttttt
Epidemiology Data
Methods
Total Prevalent Cases
Diagnosed Prevalent Cases
Total Prevalent Cases by Severity
Total Prevalent Cases by Comorbidity
Reference Materials
Literature Review
Studies Included in the Analysis of Obstructive Sleep Apnea
Studies Excluded from the Analysis of Obstructive Sleep Apnea
Risk / Protective Factors
Risk / Protective Factors for Obstructive Sleep Apnea
Bibliography
Abbreviations
Glossary
Natasha Nahar
Narendra Parihar, M.P.H., is a principal epidemiologist at Clarivate. His areas of interest are cancer epidemiology, rare disease epidemiology, and targeted therapies in cancer. A former dentist, he earned his M.P.H. from the Tata Institute of Social Sciences in Mumbai.
